Clinical Predictors of Survival in Idiopathic Pulmonary Fibrosis
Ji Hye Kim, Jin Hwa Lee, Yon Ju Ryu, Jung Hyun Chang
Tuberc Respir Dis. 2012;73(3):162-168.   Published online 2012 Sep 28     DOI: https://doi.org/10.4046/trd.2012.73.3.162
Citations to this article as recorded by Crossref logo
A Systematic Review of the Prognostic Significance of the Body Mass Index in Idiopathic Pulmonary Fibrosis
Angelo Zinellu, Ciriaco Carru, Pietro Pirina, Alessandro G. Fois, Arduino A. Mangoni
Journal of Clinical Medicine.2023; 12(2): 498.     CrossRef
Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis
Qiang Zheng, Ingrid A. Cox, Julie A. Campbell, Qing Xia, Petr Otahal, Barbara de Graaff, Tamera J. Corte, Alan K.Y. Teoh, E. Haydn Walters, Andrew J. Palmer
ERJ Open Research.2022; 8(1): 00591-2021.     CrossRef
Outcome of patients who were incidentally diagnosed with idiopathic pulmonary fibrosis: How early in the disease should we identify patients?
Ryo Yamazaki, Osamu Nishiyama, Kazuya Yoshikawa, Yuji Tohda, Hisako Matsumoto
Respiratory Medicine.2022; 201: 106933.     CrossRef
Body mass index and in-hospital mortality in patients with acute exacerbation of idiopathic pulmonary fibrosis
Nobuyasu Awano, Taisuke Jo, Hideo Yasunaga, Minoru Inomata, Naoyuki Kuse, Mari Tone, Kojiro Morita, Hiroki Matsui, Kiyohide Fushimi, Takahide Nagase, Takehiro Izumo
ERJ Open Research.2021; 7(2): 00037-2021.     CrossRef
Dynapenia is highly prevalent in older patients with advanced idiopathic pulmonary fibrosis
Marialuisa Bocchino, Paola Alicante, Ludovica Capitelli, Anna Agnese Stanziola, Lorena Gallotti, Ada Di Gregorio, Gaetano Rea, Alessandro Sanduzzi Zamparelli, Luca Scalfi
Scientific Reports.2021;[Epub]     CrossRef
Nutrition in Patients with Idiopathic Pulmonary Fibrosis: Critical Issues Analysis and Future Research Directions
Paola Faverio, Marialuisa Bocchino, Antonella Caminati, Alessia Fumagalli, Monica Gasbarra, Paola Iovino, Alessandra Petruzzi, Luca Scalfi, Alfredo Sebastiani, Anna Agnese Stanziola, Alessandro Sanduzzi
Nutrients.2020; 12(4): 1131.     CrossRef
Real-world experiences: Efficacy and tolerability of pirfenidone in clinical practice
Chuling Fang, Hui Huang, Jian Guo, Martin Ferianc, Zuojun Xu, Gernot Zissel
PLOS ONE.2020; 15(1): e0228390.     CrossRef
Pleuroparenchymal fibroelastosis in patients with idiopathic pulmonary fibrosis
Song‐I. Lee, Eun Jin Chae, Joon Seon Song, Jae Ha Lee, Jin Woo Song
Respirology.2020; 25(10): 1046.     CrossRef
Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact
Martina Bonifazi, Nicola Sverzellati, Eva Negri, Joseph Jacob, Ryoko Egashira, Joanna Moser, Sara Piciucchi, Federico Mei, Angelo De Lauretis, Dina Visca, Nicole Goh, Matteo Bonini, Laura Cirilli, Carlo La Vecchia, Felix Chua, Vasileios Kouranos, George M
European Respiratory Journal.2020; 56(1): 1902135.     CrossRef
Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review
Yet H. Khor, Yvonne Ng, Hayley Barnes, Nicole S.L. Goh, Christine F. McDonald, Anne E. Holland
European Respiratory Review.2020; 29(157): 190158.     CrossRef
Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis
Yuya Aono, Yutaro Nakamura, Masato Kono, Hidenori Nakamura, Koshi Yokomura, Shiro Imokawa, Mikio Toyoshima, Hideki Yasui, Hironao Hozumi, Masato Karayama, Yuzo Suzuki, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui, Takafumi Suda
Therapeutic Advances in Respiratory Disease.2020; 14: 175346662095378.     CrossRef
Impact of Body Mass Index on Activities of Daily Living in Patients with Idiopathic Interstitial Pneumonias
Kengo Shirado, Hidetaka Wakabayashi, Keisuke Maeda, Ryo Momosaki
Healthcare.2020; 8(4): 385.     CrossRef
The Interstitial Lung Disease-Gender-Age-Physiology Index Can Predict the Prognosis in Surgically Resected Patients with Interstitial Lung Disease and Concomitant Lung Cancer
Fumika Ueno, Yoshiaki Kitaguchi, Takayuki Shiina, Shiho Asaka, Masanori Yasuo, Yosuke Wada, Takumi Kinjo, Akihiko Yoshizawa, Masayuki Hanaoka
Respiration.2020; 99(1): 9.     CrossRef
Assessing Patterns of Palliative Care Referral and Location of Death in Patients with Idiopathic Pulmonary Fibrosis: A Sixteen-Year Single-Center Retrospective Cohort Study
Richard H. Zou, Mehdi Nouraie, Xiaoping Chen, Melissa I. Saul, Naftali Kaminski, Kevin F. Gibson, Daniel J. Kass, Kathleen O. Lindell
Journal of Palliative Medicine.2019;[Epub]     CrossRef
Comparison of disease progression subgroups in idiopathic pulmonary fibrosis
Miia Kärkkäinen, Hannu-Pekka Kettunen, Hanna Nurmi, Tuomas Selander, Minna Purokivi, Riitta Kaarteenaho
BMC Pulmonary Medicine.2019;[Epub]     CrossRef
Efficacy of pirfenidone for the treatment of pulmonary fibrosis
Shu-Min Li, Yang Lin, Shan-Shan Liang
Medicine.2019; 98(17): e15407.     CrossRef
Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry
Jaana Kaunisto, Eija-Riitta Salomaa, Ulla Hodgson, Riitta Kaarteenaho, Hannu Kankaanranta, Katri Koli, Tero Vahlberg, Marjukka Myllärniemi
ERJ Open Research.2019; 5(3): 00170-2018.     CrossRef
Prognostic factors and outcomes in Japanese lung transplant candidates with interstitial lung disease
Kohei Ikezoe, Tomohiro Handa, Kiminobu Tanizawa, Toyofumi F. Chen-Yoshikawa, Takeshi Kubo, Akihiro Aoyama, Hideki Motoyama, Kyoko Hijiya, Shinsaku Tokuda, Yoshinari Nakatsuka, Yuko Yamamoto, Ayako Oshima, Shin-ichi Harashima, Sonoko Nagai, Toyohiro Hirai,
PLOS ONE.2017; 12(8): e0183171.     CrossRef
Predicting Life Expectancy for Pirfenidone in Idiopathic Pulmonary Fibrosis
Mark Fisher, Steven D. Nathan, Christian Hill, Jade Marshall, Fred Dejonckheere, Per-Olof Thuresson, Toby M. Maher
Journal of Managed Care & Specialty Pharmacy.2017; 23(3-b Suppl): S17.     CrossRef
Current best practice in rehabilitation in interstitial lung disease
Atsuhito Nakazawa, Narelle S. Cox, Anne E. Holland
Therapeutic Advances in Respiratory Disease.2017; 11(2): 115.     CrossRef
Respiratory and lower limb muscle function in interstitial lung disease
Marios Panagiotou, Vlasis Polychronopoulos, Charlie Strange
Chronic Respiratory Disease.2016; 13(2): 162.     CrossRef
Validation of the GAP Score in Korean Patients With Idiopathic Pulmonary Fibrosis
Eun Sun Kim, Sun Mi Choi, Jinwoo Lee, Young Sik Park, Chang-Hoon Lee, Jae-Joon Yim, Chul-Gyu Yoo, Young Whan Kim, Sung Koo Han, Sang-Min Lee
Chest.2015; 147(2): 430.     CrossRef
Valeur pronostique de l'indice de masse corporelle au cours de la fibrose pulmonaire idiopathique
C. Goyard, I. Touil
Revue des Maladies Respiratoires Actualités.2015; 7(2): 161.     CrossRef
Distinct Characteristics of Pleuroparenchymal Fibroelastosis With Usual Interstitial Pneumonia Compared With Idiopathic Pulmonary Fibrosis
Tsuneyuki Oda, Takashi Ogura, Hideya Kitamura, Eri Hagiwara, Tomohisa Baba, Yasunori Enomoto, Tae Iwasawa, Koji Okudela, Tamiko Takemura, Fumikazu Sakai, Yoshinori Hasegawa
Chest.2014; 146(5): 1248.     CrossRef